EU patents approved for Quantum


Quantum is ValitaCell’s pioneering technology that powers a range of products including ValitaTiter. Innovation and the creation of ‘new to world’ technologies is central to ValitaCell’s culture. The creation and IP protection of our technologies is a key competitive advantage for our business and we are delighted that the EU has recognised the uniqueness of Quantum with an additional two patents.

The awarded patents are:

European patent No. 3170004. ‘A method of measuring antibody concentration in a sample’

European patent No. 3391049. ‘A method of determining the abundance of a target molecule in a sample’

Further Reading

Want to talk about our products?

Hi, I’m Eligio, Business Development Manager at ValitaCell. Fill in the form to the right and I’ll get in touch with you soon!